Market News AIOpen the app

CBIO stock news · Crescent Biopharma, Inc.

Stories about Crescent Biopharma, Inc. (CBIO) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for CBIO

Follow Crescent Biopharma, Inc. (CBIO) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CBIO
Free on the App Store and Google Play, or on the web.
  1. Oct 15, 2026, 4:28 PM ET · Market

    Crescent Biopharma, Inc. shares news about its drug trials and new studies starting.

    Good for CBIO

    Crescent moved several cancer-drug studies forward and plans more trials. This supports its prospects, but patient-response results are still ahead.

  2. Oct 15, 2026, 4:28 PM ET · Market

    Crescent Biopharma, Inc. shares news about its drug trials and new studies.

    Good for CBIO

    Crescent moved several cancer-drug studies forward, and U.S. regulators allowed its CR-002 study to proceed. This supports its prospects, though results showing whether the drugs work are still ahead.

  3. Sep 29, 2026, 8:23 AM ET · Market

    12 health care stocks are changing a lot before the market opens on Tuesday.

    Neutral

    Crescent Biopharma was listed among pre-market gainers. The article gives no company news explaining the move, so it does not change the view of its business.